50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to provide access to best-in-class treatments for patients who have little to no treatment options.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-02-2789% match
“Our mission is to provide transformative therapies to patient communities who have inadequate or no therapeutic options available to address these debilitating diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-0874% match
“Our mission is to provide therapeutic relief to those suffering from debilitating rare diseases that have limited or no treatment options to help them live their best possible lives and achieve their full potential.”In use 2024 – now·1 sighting·SEC Form 20-F, filed 2024-04-3072% match
“Our mission is to simplify access to complex therapies and improve health outcomes for patients with chronic, rare, or specialty conditions.”In use 2025 – now·1 sighting·SEC Form S-1, filed 2025-11-0771% match
“Our mission is to improve the lives of patients who suffer from rare diseases for which there are limited or no available treatments, with an initial therapeutic focus on Cirrhosis ascites, patients suffering from AIDS, Cancer and chronic pain, nausea and discomfort associated with chemotherapy and neuropathy.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-11-0670% match
“Our purpose is to deliver therapies for significant unmet, or under-met, needs to patients, while creating value for our investors.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-03-1669% match
“Our mission is to make exceptional concierge-level healthcare more accessible to people in the communities we serve.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0569% match
“Our mission is to develop innovative therapies that can transform patients' lives by addressing areas of high unmet medical need.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2368% match
“Our mission is to improve patients’ lives by identifying, developing and commercializing products that address unmet medical needs.”In use 2013 – now·1 sighting·SEC Form 10-K, filed 2013-02-2668% match
“Our mission is to serve patients.”In use 2012 – now·1 sighting·SEC Form 10-K, filed 2012-02-2968% match
“Our mission is to enable patients with these disorders to live fuller and healthier lives through the discovery and development of transformative therapies that overcome the key limitations of currently available treatments.”In use 2026 – now·1 sighting·SEC Form 424B4, filed 2026-08-1268% match
“Our mission is to discover and develop best- and first-in-class medicines for a broad range of difficult-to-treat diseases in collaboration with our partners.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-04-0868% match
“Our mission is to create and advance new medicines for patients suffering from serious and rare diseases that are underserved by today’s therapies.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2668% match
“Our mission is to do so at a scale that allows broad accessibility for patients so that we can democratize access to curative therapies.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-02-0567% match
“Our mission is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.”In use 2007 – now·1 sighting·SEC Form 10-K, filed 2007-02-2867% match
“Our mission is to provide better treatment options than those that presently exist by extending a patient’s survival and/or improving a patient’s quality of life.”In use 2025 – now·1 sighting·SEC Form 424B4, filed 2025-01-2967% match
“Our mission is to bring to market therapies that address high unmet medical needs of patients with genetic mitochondrial diseases.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2767% match
“Our mission is to develop a variety of first-in-class and best-in-class product candidates customized in an effort to optimize safety, efficacy, and convenience that we believe may offer improved patient experiences.”In use 2010 – now·1 sighting·SEC Form 10-K, filed 2010-03-1567% match
“Our mission is to improve health for all with great, innovative, affordable medicines so that people with life-changing or chronic conditions can gain access to the medicines they need, physicians can treat patients without barriers to prescribing, and health systems can afford to make those medicines available, without restrictions, to the populations they serve in a financially sustainable manner.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-2367% match
“Our mission is to provide high quality, highly accessible healthcare for all, empowering the delivery of mobile healthcare and medical transportation outside of traditional “brick-and-mortar” facilities, with more accessible, affordable and efficient patient-centered care.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-02-2767% match
“Our mission is to improve the lives of patients and assist their care providers by delivering novel therapies that improve outcomes while reducing the undesirable side effects of many current therapies.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-03-1567% match
“Our mission is to develop and commercialize novel and best-in-class therapeutics to address unmet medical needs in the emerging otology market.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-03-1866% match
“Our mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-06-2866% match
“Our mission is to advance drug-free neuromodulation therapies that improve patient outcomes and reduce medication burden in complex disorders, while expanding access to effective care for populations with significant unmet needs.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1966% match
“Our mission is to use software to treat disease directly and increase access to care for patients, including underserved constituents of the healthcare ecosystem.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-3166% match
“Our mission is to enable physicians to provide the right treatment, at the right time, for the right patient.”In use 2010 – now·1 sighting·SEC Form 10-K, filed 2010-03-0466% match
“Our mission is to bring hope with life-changing therapies to patients and families that are affected by rare and niche allergic and immunological diseases.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2266% match
“Our mission is to develop innovative, patient-friendly and easy-to-use treatments that empower people with allergies and their caregivers to treat at the first sign of symptoms.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0966% match
“Our mission is to alleviate the most human suffering possible by developing active immunotherapy product candidates that improve the quality of care for chronic diseases and are accessible to all patients across the globe.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2766% match
“Our mission is to develop and commercialize first-in-class medicines based on novel targets to improve patients’ lives.”In use 2022 – now·1 sighting·SEC Form 20-F, filed 2022-03-2466% match
“Our mission is to provide best-in-class home health, hospice and high acuity care services allowing our patients to maintain a sense of independence, quality of life and dignity while delivering industry leading outcomes.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-02-2765% match
“Our mission is to develop innovative products to address unmet medical needs and to improve the quality of life of our patients.”In use 2006 – now·1 sighting·SEC Form 20-F, filed 2006-02-2865% match
“Our mission is to benefit patients by developing and commercializing anti-cancer therapies for patients whose solid tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, with particular focus on orphan cancer indications.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-10-0765% match
“Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3065% match
“Our mission is to build a leading oncology company that creates novel and transformative treatments for a wide range of oncology indications for which there are significant unmet medical needs.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-0765% match
“Our mission is to get the right drugs to the right patients.”In use 2006 – now·1 sighting·SEC Form S-1, filed 2006-04-1065% match
“Our mission is to transform the lives of patients by creating medicines with improved therapeutic profiles for areas of unmet need.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2365% match
“Our mission is to develop and commercialize therapies with the potential to transform the lives of patients and their families living with rare diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-0165% match
“Our mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest unmet medical need – aggressive cancers where current therapies are inadequate.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-02-2965% match
“Our mission is to make high-quality, personalized healthcare affordable and accessible for all our patients.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-06-2865% match
“Our mission is to improve overall patient condition through innovative bio-immunotherapy with proven treatment protocols, to lower deaths associated with cancer and to reduce the cost of cancer treatment.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-2565% match
“Our mission is to provide high quality healthcare in the communities we serve and to provide services in an affordable and accessible manner in a patient-friendly environment.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-03-2765% match
“Our mission is to discover and develop novel therapeutic drugs to treat diseases and disorders for which there are no adequate therapies or for which a new drug would represent a significant advancement over the current therapy.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-03-1465% match
“Our mission is to improve the quality of care and health of patients suffering from gastrointestinal diseases and disorders by providing effective therapies for patients and specialized caregivers.”In use 2009 – now·1 sighting·SEC Form 10-K, filed 2009-12-1765% match
“Our mission is to advance novel therapies, leveraging evidence-based innovation, with the potential to transform the lives of people suffering from serious, chronic conditions and unmet medical needs.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-09-2565% match
“Our mission is to build an oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0365% match
“Our mission is to bring life-changing therapeutics to people living with rare diseases.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1265% match
“Our mission is to provide superior treatment options for complex diseases and disorders to improve the lives of patients by developing innovative new medicines that exploit the unique role of NNRs.”In use 2012 – now·1 sighting·SEC Form 10-K, filed 2012-03-0664% match
“Our mission is to improve the lives of patients with CF by providing novel and cost-effective treatment options.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-1064% match
“Our mission is to improve clinical outcomes and enhance the choices available to end users while increasing the availability and affordability of healthcare in general.”In use 2013 – now·1 sighting·SEC Form S-1/A, filed 2013-02-1364% match
Showing 1–50 of 50